Open AccessSurvival After Surgery for Renal Cell Carcinoma Metastatic to the Spine: Impact of Modern Systemic Therapies on Outcomes
Author(s) -
Ganesh M. Shankar,
Laura A Van Beaver,
Bryan D. Choi,
Muhamed Hadzipasic,
Ahilan Sivaganesan,
Aditya V. Karhade,
Marco Ferrone,
Mitchel B. Harris,
Andrew J. Schoenfeld,
Peter M. Sadow,
Kevin Oh,
Joseph H. Schwab,
Philip J. Saylor,
John H. Shin
Publication year - 2020
Publication title -
neurosurgery/neurosurgery online
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.455
H-Index - 198
eISSN - 1081-1281
pISSN - 0148-396X
DOI - 10.1093/neuros/nyaa224
Subject(s) - medicine , systemic therapy , renal cell carcinoma , cohort , interquartile range , surgery , cancer , kidney cancer , radiosurgery , oncology , radiation therapy , breast cancer
Modern medical management of metastatic renal cell carcinoma (RCC) includes therapies targeting tyrosine kinases, growth pathways (mammalian target of rapamycin (mTOR)), and immune checkpoints.